InCarda Therapeutics

NanoPhoria

This company develops an inhalable nano-drug delivery platform and therapeutics for patients with heart failure and other cardiovascular diseases.

Milestone Pharmaceuticals

This biopharmaceutical company develops and commercialises self-administered nasal sprays for patients suffering from episodic cardiovascular conditions like paroxysmal supraventricular tachycardia.

Cardior Pharmaceuticals

This biopharmaceutical company develops RNA-based therapeutics to prevent and repair heart disease for patients with conditions such as heart failure and myocardial infarction.

AnaCardio

This biopharmaceutical company develops oral small-molecule drugs to improve cardiac contractility in patients with heart failure.

Respira

This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.

preCARDIA

This company develops catheter-based systems for heart failure specialists to treat patients suffering from acute decompensated heart failure and volume overload.

Cardurion Pharmaceuticals

This clinical-stage biotechnology company develops therapeutic drugs for patients with heart failure and other cardiovascular diseases.